Treatment Options to Reduce Disease Activity After Natalizumab: Paradoxical Effects of Corticosteroids. Rossi S, Motta C, Studer V, Boffa L, De Chiara V, Castelli M, Barbieri F, Buttari F, Monteleone F, Germani G, et al. CNS Neurosci Ther. 2014 May 19. PMID: 24837039. Abstract CommentRecommendBookmarkWatch